Specifically, certain BCL6 FISH probes can misinterpret a single MYC rearrangement as dual oncogenic events by detecting both BCL6 promoter and MYC-BCL6 enhancer rearrangements, thereby inflating triple-hit lymphoma rates [33–36]. This evidence concerns the gene BCL6 and lymphoma.